FOS (Fructooligosaccharides).

Bifidobacteria carry the fructofuranosidase enzymes that split short-chain fructans, so FOS is a substrate this species can use where most gut organisms cannot. Pairing the fibre with the organism gives the delivered culture something to ferment on arrival.

B. lactis ferments short-chain fructans through the bifid shunt, turning FOS into lactate and acetate. The fibre acts as the carbon source that supports the co-dosed strain in the colon.

B. infantis is adapted to oligosaccharide fermentation and takes up short-chain fructans readily. FOS supplies the substrate that lets the strain hold its niche rather than passing through.

Lactobacilli ferment FOS to lactic acid, which lowers luminal pH and favours their own growth over acid-sensitive organisms. The classic synbiotic pairing puts the fibre and the culture in one dose for this reason.

L. rhamnosus uses short-chain fructans as a fermentable carbon source and acidifies its local environment as it does. Co-dosing the fibre supports colonisation of the delivered strain.

FOS is the short-chain end of the same beta-2,1 fructan family as inulin, so it ferments early in the colon while longer inulin chains carry further along. Combining the two spreads fermentation across more of the colon instead of loading the proximal segment.

GOS and FOS are fermented by overlapping but not identical enzyme sets, so together they support a wider set of bifidobacteria than either alone. The pairing is standard practice in prebiotic blends.

Fructan fermentation yields acetate and lactate that butyrate-producing bacteria cross-feed on, so FOS raises endogenous butyrate from the inside. Direct butyrate covers the proximal colon while the fibre keeps production running distally.

Short-chain fatty acids from fructan fermentation lower colonic pH, which keeps calcium in a soluble ionised form available for absorption across the large bowel. This is the established mechanism behind pairing fructans with calcium salts.

The same drop in colonic pH from fructan fermentation keeps magnesium soluble at the distal absorptive sites. The effect is smaller than for calcium but works through the identical route.

FOS ferments fast and proximally while resistant starch ferments slowly and reaches the distal colon. Using both spreads short-chain fatty acid production over a longer stretch of bowel.

XOS has a xylose backbone needing different bacterial enzymes than the fructose backbone of FOS, so the two feed partly different organisms. Blending them broadens which resident populations respond.

Unabsorbed magnesium citrate draws water into the lumen while fermenting FOS generates gas and osmotically active short-chain acids. Stacking both at higher doses adds up to bloating and loose stools, so the doses are usually staggered.

Glucomannan is highly fermentable and viscous, and FOS ferments rapidly, so the two together raise total gas production in the proximal colon. Sensitive users notice the additive distension before either fibre alone would cause it.

FOS is a fermentable substrate that human enzymes cannot cleave, so it arrives in the colon intact and is available to bacteria that carry beta-fructofuranosidase. Delivering the substrate with the organisms is the definition of a synbiotic. Which strains gain depends on their enzyme repertoire, not on the dose of FOS alone.

Many Lactobacillus species ferment short-chain fructans through a fructose-specific phosphotransferase route and produce lactate from them. Lactate is then cross-fed to butyrate producers in the same community. Strain-level differences in fructan utilisation are large, so a strain that cannot use FOS gains nothing from it.

S. boulardii is a yeast, not a fructan specialist, and it does not rely on FOS the way bifidobacteria do. Combining them means the yeast acts on its own terms while FOS feeds the resident bacterial community. This is a co-formulation rationale rather than a fed relationship.

L. plantarum carries a broad set of carbohydrate transporters and can grow on short-chain fructans in culture. Pairing it with FOS supplies the substrate at the site where the organism lands. Growth in culture is a laboratory observation and does not by itself predict colonic behaviour.

Lactoferrin promotes bifidobacterial growth by a route unrelated to fermentable carbohydrate, partly through iron sequestration that disadvantages competitors. FOS feeds the same organisms with a substrate. Two independent pushes on one population, which is why infant and gut formulas pair them.

Bovine colostrum carries its own milk oligosaccharides plus glycoproteins that resist digestion, so it contributes fermentable material of a different structure to FOS. The two substrate classes select somewhat different taxa. The combined effect on the community has not been characterised.

Psyllium is a viscous, poorly fermented gel-forming fibre that holds water in the stool, while FOS is rapidly and almost completely fermented with little bulking. They act by opposite physical mechanisms, which is precisely why they are combined. Trade-off: the rapidly fermented fraction is the one that generates gas, and the viscous one is not.

Guar gum is viscous and slowly fermented along the length of the colon, whereas FOS is fermented fast and largely in the proximal colon. Combining a fast and a slow substrate spreads short-chain fatty acid production more evenly. Adding two fermentable fibres also adds their gas production together, which is the practical limit on the pairing.

Hydrolysis strips most of guar's viscosity while leaving it fermentable, giving a low-viscosity substrate fermented more gradually than FOS. Paired with FOS it extends the fermentation window without the thickening. Both are fermentable, so cumulative gas remains the trade-off to watch.

Pectin is a galacturonan fermented by a different enzymatic guild than the fructan degraders that handle FOS. Different substrates recruit different specialists, which broadens rather than deepens the fermentation. This is substrate chemistry, not a tested combination.

Oat beta-glucan is a viscous mixed-linkage glucan whose main measured effects run through viscosity in the small intestine, upstream of where FOS does anything. FOS contributes colonic fermentation instead. The two occupy different segments of the gut.

Fermentation of FOS lowers luminal pH, and iron stays more soluble at lower pH, which is the mechanism behind reported increases in colonic mineral uptake. Colonic absorption is a minor route for iron compared with the duodenum, so the effect is modest by construction. The pH change is a measured mechanism; a change in iron status is a separate question.

Several bifidobacteria synthesise folate and export it into the lumen, and expanding those populations with a fructan substrate raises microbial folate production in fermentation systems. Colonic folate absorption exists but contributes far less than dietary intake. The measurement is luminal folate, a marker, not a change in a person's folate status.

Parts of the colonic community synthesise riboflavin, and riboflavin also acts as an electron shuttle in gut redox chemistry. Feeding the community a fermentable fructan changes who is present and therefore what is produced. This is a mechanistic link with no human outcome attached.

Quercetin glycosides that escape small-intestinal absorption are deglycosylated and ring-fissioned by colonic bacteria into the metabolites that actually circulate. The bacteria doing that work are shaped by the fermentable substrate available. Whether FOS specifically shifts quercetin metabolite output has not been measured.

A preliminary clinical report examined prebiotics given with beta-hydroxy-beta-methylbutyrate for muscle-related measures in older people, and describes the pairing as acting together. FOS is named among the prebiotics in that literature rather than isolated as the tested substrate. Read this as an early combination signal, not a result specific to FOS.

Zinc solubility also rises as luminal pH falls, so the fermentation mechanism is theoretically relevant. Most zinc absorption occurs proximal to the site of FOS fermentation, which limits how much this can matter. Early confidence and page only, for that reason.

Several colonic bacteria synthesise menaquinones, so changing the microbial community can change local menaquinone production. How much of that bacterial vitamin K reaches systemic circulation is uncertain and generally considered limited. Flagged at early confidence as a mechanism, not as a source claim.

Most of an oral catechin dose reaches the colon and is broken down there into phenolic acids and valerolactones by resident bacteria. A prebiotic changes that community, so it has a theoretical route to changing which metabolites appear. Early confidence, and no pairing study is cited.

Human brush-border enzymes leave FOS intact, but fungal-derived invertase and inulinase in some enzyme blends do cleave beta-2,1 fructosyl bonds. Where that happens in the upper gut, part of the FOS is released as free fructose and never reaches the colon as substrate. Worth flagging as a formulation and timing consideration, since it works against the reason FOS is being taken.

Berberine has poor systemic bioavailability and much of its described activity is attributed to effects on the gut microbial community and on bacterial metabolites. A prebiotic acts on the same community by supplying substrate. Whether they reinforce or oppose each other in a person is not established, so this is recorded as modulating at early confidence.